| Asset Classes | Listed equity |
|---|---|
| Impact strategy | Impact Equities and Bonds |
| Sector | Healthcare |
| Bloomberg ticker | GN DC |
| ISIN code | DK0010272632 |
| Industry group | Health Care Equipment |
| Aligned with SDGs |
GN Store Nord A/S develops, manufactures, and markets medical, professional, and consumer audio solutions. The company operates through GN Hearing and GN Audio segments. The GN Hearing segment produces and sells hearing instruments and products for people with hearing loss. The GN Audio segment supplies headsets and speakerphone solutions primarily for professional use; and consumer headsets and earbuds for calls, music, and media consumption. GN has central manufacturing sites in China, Malaysia and Denmark. GN's hearing aids are sold in 100 countries, between Denmark, rest of Europe, North America, and internationally. GN has its own operations in 30 countries and operates via partners in another 70 countries. GN Store Nord A/S was founded in 1869, currently has 6,525 employees and is headquartered in Ballerup, Denmark.
Investment rationale
Hearing impairment is a common health challenge in societies nowadays, mostly affecting elderly people, but also younger people with risk factors such as childhood illnesses or too much exposure to loud noise or music. This health condition prevents individuals from fully participating in social situations, diminishing their quality of life. GN Store Nord is one of the leading manufacturers of hearing aid devices. By providing hearing aid products, the company helps people with impaired hearing overcome their health challenges. The company also offers other audio equipment for professional and recreational use. Thus GN contributes to increasing productivity in the workplace and helps people increase their fitness with its wireless headsets for mobile users that allow an active lifestyle. With its strategic focus on innovation, aiming to make life sound better, GN sponsors external acoustic and hearing research.